SCHEMBL9521097

SCHEMBL9521097

CC(=O)NCC1CN(c2ccc(C=O)cc2)C(=O)O1

nearest known ligand 0.57

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.57
MAOB P27338 2/20 0.57
LMNA P02545 1/20 0.57
PTGS1 P23219 1/20 0.57
CALML3 P27482 1/20 0.57
SDHA P31040 1/20 0.57
F10 P00742 7/20 0.55
ABCB11 O95342 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7531429 1.00 MAOA (0.57) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL9550298 0.96 MAOA (0.54) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL10394771 0.89 MAOA (0.53) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL13298924 0.87 MAOA (0.61) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL9521339 0.86 MAOA (0.53) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL15367964 0.86 MAOA (0.60) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL9550292 0.86 MAOA (0.60) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL16703808 0.86 MAOA (0.60) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL22808199 0.86 MAOA (0.54) MAOAMAOBLMNAPTGS1CALML3
SCHEMBL4573665 0.86 MAOA (0.65) MAOAMAOBLMNAPTGS1CALML3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0316594-B1 AMINOMETHYL OXOOXAZOLIDINYL ETHENYLBENZENE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-09-29 EP disclosed
US-4977173-A Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-12-11 US disclosed
EP-0316594-A1 Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1989-05-24 EP disclosed